SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
SLN fundamentals
Silence Therapeutics (SLN) Revenue Breakdown: Q3 2025 Business & Regional Performance
Silence Therapeutics (SLN) reported total revenue of 159.00K USD in Q3 2025, with its core business segment Research Collaboration contributing 100.00%. Regionally, United Kingdom remained the largest market, accounting for 100.00% of total revenue. Explore Silence Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Silence Therapeutics (SLN) reported total revenue of 159.00K USD in Q3 2025, with its core business segment Research Collaboration contributing 100.00%. Regionally, United Kingdom remained the largest market, accounting for 100.00% of total revenue. Explore Silence Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for Silence Therapeutics year over year?What factors drove the changes in Silence Therapeutics's revenue and profit?What were the key takeaways from Silence Therapeutics’s earnings call?What is Silence Therapeutics's gross profit margin?What guidance did Silence Therapeutics's management provide for the next earnings period?What is Silence Therapeutics's latest dividend and current dividend yield?Did Silence Therapeutics beat or miss consensus estimates last quarter?What does Silence Therapeutics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
